Virpax Pharmaceuticals Inc. (NASDAQ: VRPX)
$0.7100
+0.0110 ( +1.57% ) 4.0K
Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.
Market Data
Open
$0.7100
Previous close
$0.6990
Volume
4.0K
Market cap
$3.42M
Day range
$0.6680 - $0.6880
52 week range
$0.3625 - $8.0000
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 10-q | Quarterly Reports | 57 | Aug 12, 2024 |
| 8-k | 8K-related | 15 | Jul 30, 2024 |
| 8-k | 8K-related | 13 | Jul 26, 2024 |
| 8-k | 8K-related | 15 | Jul 24, 2024 |
| 3 | Insider transactions | 2 | Jul 15, 2024 |
| 8-k | 8K-related | 13 | Jul 15, 2024 |
| 4 | Insider transactions | 1 | Jul 10, 2024 |
| 3 | Insider transactions | 2 | Jul 10, 2024 |
| 8-k | 8K-related | 15 | Jul 10, 2024 |
| 4 | Insider transactions | 1 | Jul 09, 2024 |